See the DrugPatentWatch profile for yupelri
Generic Yupelri Availability
As of early 2024, there are no generic versions of Yupelri (revefenacin) available in the United States [1]. Yupelri is a long-acting muscarinic antagonist (LAMA) used to treat chronic obstructive pulmonary disease (COPD) [2].
Why Isn't There a Generic Yupelri Yet?
The absence of generic Yupelri is primarily due to patent protections and the time required for generic drug development and approval [3]. Developing a generic equivalent involves demonstrating bioequivalence to the branded drug, which is a complex and time-consuming process [4]. Drug patents typically grant market exclusivity for a certain period, preventing generic competition until they expire [3].
When Might Generic Yupelri Become Available?
The patent landscape for Yupelri, like other branded medications, dictates when generic versions can enter the market. Information on specific patent expiry dates and any ongoing legal challenges can often be found through resources that track drug patents [1]. Generally, patent terms can be extended, and litigation can delay generic entry [3].
What Is Yupelri Used For?
Yupelri is prescribed for the maintenance treatment of COPD in adults [2]. It works by relaxing the muscles around the airways in the lungs, making it easier to breathe [5].
How Does Yupelri Work?
Yupelri is a long-acting muscarinic antagonist (LAMA). It blocks the action of acetylcholine, a neurotransmitter that causes bronchoconstriction (narrowing of the airways). By blocking acetylcholine, Yupelri allows the airways to relax and widen [5].
Are There Alternatives to Yupelri for COPD?
Several other medications are available for the management of COPD, including other LAMAs, long-acting beta-agonists (LABAs), and inhaled corticosteroids, often used in combination therapies [6]. The choice of treatment depends on the severity of the COPD, individual patient needs, and response to therapy [6].
What Is the Cost of Yupelri?
The cost of Yupelri can vary significantly depending on insurance coverage, pharmacy, and dosage [7]. Information on current pricing and potential patient assistance programs may be available from the drug manufacturer or through healthcare providers.
DrugPatentWatch.com and Patent Information
DrugPatentWatch.com is a resource that provides detailed information on drug patents, including expiry dates and patent litigation [1]. This type of information is crucial for understanding the timeline for generic drug market entry.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugs.com/yupelri.html
[3] https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/ANDA-patent-and-exclusivity-information
[4] https://www.fda.gov/drugs/development-approval-process-drugs/drug-development-process
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603220/
[6] https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treatment
[7] https://www.goodrx.com/yupelri